Calumet, INC /DE Form 4 insider transactions
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Daniel J. Sajkowski exercised 5,053 Restricted Stock Units, with 40% settled in cash and the remainder converted to common stock.
NASDAQ
CLMT
Calumet, INC /DEAn amended SEC filing details Calumet Director Daniel J. Sajkowski's recent acquisition and partial cash settlement of company stock and restricted stock units.
NASDAQ
CLMT
Calumet, INC /DECalumet Inc. Director Daniel J. Sajkowski executed a series of pre-scheduled stock sales totaling 82,000 shares between March and July 2025 under a Rule 10b5-1 trading plan.
NASDAQ
CLMT
Calumet, INC /DECalumet's Chief Accounting Officer, John Robert Krutz, received a grant of 2,365 restricted stock units, aligning his interests with shareholders.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc.'s EVP and CFO, David Lunin, was granted 16,866 Restricted Stock Units, aligning his interests with long-term company performance.
NASDAQ
CLMT
Calumet, INC /DECalumet's SVP and General Counsel, Gregory J. Morical, acquired 10,629 equity awards, including performance-based and service-based restricted stock units.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. executive Bruce A. Fleming received 18,550 restricted stock units, aligning his interests with long-term company performance.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. EVP of Specialties, Scott Obermeier, was granted 17,392 Restricted Stock Units as part of his compensation.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. CEO Louis Todd Borgmann received 131,984 Restricted Stock Units as part of compensation, with varying vesting schedules.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Executive Vice President Bruce A. Fleming donated 50,000 shares of common stock to a donor-advised fund for charitable purposes under a pre-arranged plan.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Karen A. Twitchell converted 2,526 Restricted Stock Units into common stock, increasing her direct beneficial ownership.
NASDAQ
CLMT
Calumet, INC /DECalumet Director Jennifer Straumins converted 5,053 restricted stock units into common stock, increasing her direct beneficial ownership.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Daniel J. Sajkowski increased his direct beneficial ownership of common stock by 3,031 shares following the vesting and partial cash settlement of Restricted Stock Units.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Raymond C. acquired 5,053 shares of common stock through the conversion of vested Restricted Stock Units, increasing his direct beneficial ownership.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director John G. Boss increased his beneficial ownership of common stock by 1,515 shares following the vesting of Restricted Stock Units.
NASDAQ
CLMT
Calumet, INC /DEAmy M. Schumacher, a Director at Calumet, Inc., acquired 5,053 shares of common stock through the conversion of Restricted Stock Units under a pre-arranged plan.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Raymond Paul C. acquired 1,708 Restricted Stock Units, with varying vesting schedules, as reported in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director John G. Boss reported the acquisition of 512 Restricted Stock Units, with varying vesting schedules.
NASDAQ
CLMT
Calumet, INC /DECalumet Director Stephen P. Mawer reported the acquisition of 2,348 Restricted Stock Units, with varying vesting schedules, effective November 6, 2025.
NASDAQ
CLMT
Calumet, INC /DECalumet Director Amy M Schumacher reported the acquisition of 1,562 Restricted Stock Units, with varying vesting schedules, as part of her compensation.
NASDAQ
CLMT
Calumet, INC /DECalumet Director Jennifer Straumins converted 3,796 Restricted Stock Units into common stock.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Karen A. Twitchell increased her direct beneficial ownership by 3,796 shares through the settlement of vested Restricted Stock Units.
NASDAQ
CLMT
Calumet, INC /DECalumet Director Amy M Schumacher converted 3,796 Restricted Stock Units into common stock, increasing her direct beneficial ownership to 246,040 shares.
NASDAQ
CLMT
Calumet, INC /DECalumet Director Raymond Paul C acquired 3,796 shares of common stock through the conversion of vested Restricted Stock Units.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Daniel J. Sajkowski vested 3,796 Restricted Stock Units, with 40% settled in cash and the remainder added to his direct ownership.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director John G. Boss reported the vesting of Restricted Stock Units and a subsequent adjustment to his common stock holdings.
NASDAQ
CLMT
Calumet, INC /DECalumet Director Stephen P. Mawer reported the acquisition and subsequent partial disposition of common stock related to vested Restricted Stock Units.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Raymond Paul C received grants of Restricted Stock Units, totaling 2,148 units, as reported in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director John G. Boss acquired a total of 644 Restricted Stock Units, including 483 fully vested units and 161 units under a deferred compensation plan.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. director Stephen P. Mawer was granted 2,954 Restricted Stock Units as part of his compensation.